 |
 |
|
|
|
| Leuprorelin Acetate |
 |
| Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt |
 |
| 53714-56-0(net) |
 |
| For the treatment of advanced hormone-dependent prostate cancer, endometriosis, advanced hormone-dependent breast cancer and central precocious puberty. |
 |
| Leuprorelin Acetate is a potent LHRH agonist. |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
